NUUU OTC
Rejuvel Bio-Sciences, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: +0.0%
1Y: -99.0%
3Y: -99.0%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±8129.4%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$494K
-65.7% ▼
Capital Expenditures
$33K
-233.3% ▼
4Y CAGR: +317.2%
Free Cash Flow
-$527K
-71.2% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$1K
+0.0% ▲
Net Change in Cash
$35K
+129.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$25K | -$228K | -$834K | -$716K | -$353K |
| Depreciation & Amort. | $7 | $4K | $4K | $4K | $7K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $4K | $590 | $9K | $250K | $210K |
| Other Non-Cash Items | $0 | $11K | $142K | $163K | -$357K |
| Operating Cash Flow | -$21K | -$212K | -$679K | -$298K | -$494K |
| — Investing Activities — | |||||
| Capital Expenditures | -$110 | -$22K | -$470 | -$10K | -$18K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$2K | $0 | $0 | -$15K |
| Investing Cash Flow | -$110 | -$23K | -$470 | -$10K | -$33K |
| — Financing Activities — | |||||
| Net Debt Issuance | $20K | $100K | $189K | $60K | -$120K |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$1K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $200K | $40K | $132K | $153K |
| Financing Cash Flow | $20K | $409K | $626K | $192K | $562K |
| Net Change in Cash | -$1K | $174K | -$54K | -$116K | $35K |
| Cash End of Period | $0 | $174K | $121K | $5K | $40K |
| Free Cash Flow | -$21K | -$235K | -$679K | -$308K | -$527K |